-
-
-
-
-
-
-
Jazz Pharmaceuticals to Participate in Upcoming November Investor Conferences
-
-
-
-
-
-
-
Jazz Pharmaceuticals (JAZZ) Likely to See 25% Accretion on GWPH, Guidance in Next 30 Days - Jefferies
-
-
-
-
-
-
-
Jazz Pharmaceuticals Announces Participation at Two Upcoming Virtual Investor Conferences
-
-
-
-
-
-
-
After Sagent (SGNT), Jefferies Sees Continued Specialty Pharma M&A
-
-
-
-
-
-
-
Jazz Pharmaceuticals and Gentium S.p.A. Announce Agreement for Jazz Pharmaceuticals to Acquire Gentium for $57.00 Per Share
-
-
-
-
-
-
-
Jefferies Says Buy the Dip in Jazz (JAZZ); Warning Letter Contained 'Nothing New'
-
-
-
-
-
-
-
Morning Movers 6/25: JAZZ, CAEI, CYTR, TWB, XRTX, CAR Higher; INSM, ACXM, GRO, TCK, RHT Lower
-
72,065 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

